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ABSTRACT
Objective: The objective of this study was to evaluate the antidiabetic potential of Bauhinia vahlii Wt. and Arn. (Caesalpiniaceae) root, a botanical 
source for Murva (Ayurveda drug).
Methods: Ethanol extract of B. vahlii root (EEBVR) and aqueous extract of B. vahlii root (AEBVR) prepared were subjected for acute toxicity study 
adopting Organisation for Economic Cooperation and Development guidelines. Antidiabetic property of EEBVR and AEBVR was screened against 
Streptozotocin-nicotinamide-induced Diabetes Mellitus (DM). The diabetic animals were administered with standard drug glibenclamide (0.5 mg/kg), 
EEBVR (200 and 400 mg/kg), and AEBVR (200 and 400 mg/kg) for 21 days. Fasting blood glucose, serum triglycerides, total cholesterol, liver 
malondialdehyde, reduced glutathione, and glycogen were estimated along with pancreatic histological analysis.
Results: EEBVR (400 mg/kg) exerted a marked antidiabetic activity among the extracts at the tested doses, as evidenced by considerable reversal of 
biochemical parameters that were well supported by the histopathological interpretation of pancreas.
Conclusion: This study confirms the antidiabetic potential of B. vahlii root and also its traditional claim in the use of DM.
Keywords: Bauhinia vahlii, Murva, Diabetes, Streptozotocin, Nicotinamide.
INTRODUCTION
Diabetes Mellitus (DM) is one of the common metabolic disorders 
significantly affecting the world population, and according to the 
International Diabetes Federation’s, 80% of the world diabetic 
population is anticipated from low- and middle-income countries 
in 2030 [1]. The treatment of DM is oriented toward oral glucose-
lowering agents such as sulfonylureas, biguanides, thiazolidinediones, 
and alpha-glucosidase inhibitors in case of non-insulin dependent type 
and insulin therapy if it is of insulin dependent. Limitation of medical 
management of diabetes is the incidence of adverse effects, so many of 
the research institutes and pharmaceutical industries are involved in 
drug development to hit on molecules with good therapeutic potential 
and less adverse events.
Traditional systems of medicine have taken care of the health needs of 
the people [2], and various herbs are documented for their promising 
results in managing various systemic disorders including diabetes. 
The dearth in reports of standardization with reference to efficacy, 
safety, and usage poses a major challenge in the development of those 
traditional herbal medicines. Murva is a widely used drug in Ayurveda 
and the formulations containing Murva root are reported to be used in 
the treatment of Meha, Prameha (prediabetes disorder), Madhumeha 
(diabetes), Kustha (skin diseases), Netra roga (eye diseases), Pandu 
(anemia), Jvara (fever), Hrdroga (Cardiac disorders), and Gulma 
(abdominal disorders) [3]. Although the accepted botanical source 
for Murva is Marsdenia tenacissima (Roxb.) Moon (Asclepiadaceae) 
[4], there are many other plant species being used in the same 
drug name and one such species is Bauhinia vahlii Wt. and Arn. 
(Caesalpiniaceae) [5]. Antibacterial and antifungal property of B. vahlii 
root [6] has already been reported, while there is no comprehensive 
report on the antidiabetic property [7]. Hence, the present study 
was planned to explore the antidiabetic activity of B. vahlii root in 
Streptozotocin (STZ)-nicotinamide (NA)-induced DM. This work will 
also substantiate the traditional use and provide an alternate source for 
the drug Murva in Ayurveda.
MATERIALS AND METHODS
Plant material
B. vahlii root was collected during September 2011 from Tirumala hills, 
Andhra Pradesh, India and authenticated using local flora. A voucher 
herbarium specimen (SS 048) was prepared as per the standard 
procedure [8] and deposited at the Department of Pharmacognosy, 
Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, 
Bengaluru, for future reference.
Chemicals and reagents
Biochemical assay kits for the estimation of serum triglycerides (TG) 
and total cholesterol (TC) were procured from Agappe Diagnostics, 
India. STZ was obtained from Spectrochem Pvt. Ltd., India. All other 
chemicals and solvents used were of analytical grade.
Extraction
B. vahlii root was cleaned, shade dried, and coarsely powdered. 
Ethanol extract of B. vahlii root (EEBVR) was prepared using 95% v/v 
ethanol, and aqueous extract of B. vahlii root (AEBVR) was prepared by 
macerating in distilled water with 0.25% v/v of chloroform. Both the 
extracts were concentrated to dryness and refrigerated till further use.
Phytochemical screening
A preliminary phytochemical analysis of EEBVR and AEBVR was 
performed for the identification of various phytoconstituents using 
standard procedures [9].
Animals
Albino Wistar rats of both sex in the weight range of 220–250 g were 
housed at 24±2°C, fed with standard pellet diet and water ad libitum. 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i4.31373
Research Article
The Institutional Animal Ethics Committee approved the protocol of 
this study (Approval No.: MSRCP/P-12/011).
Acute toxicity
Acute oral toxicity of EEBVR and AEBVR was studied as per the 
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guidelines [10]. A single oral dose of 2000 mg/kg was administered to 
overnight fasted animals and observed continuously for first 3 h for its 
behavioral profile, neurological profile, and autonomic response and 
thereafter for every 24 h till 21 days.
Antidiabetic activity
Induction of diabetes and treatments
Diabetes was induced in overnight fasted animals by a single dose of 
freshly prepared NA (110 mg/kg, i.p.,) in normal saline followed by STZ 
(45 mg/kg, i.p.,) in citrate buffer 15 min later. After 4 days of STZ-NA 
administration, the animals with fasting blood glucose levels >200 mg/dl 
were considered diabetic [11,12]. A total of 42 diabetic animals 
were divided into seven groups (n=6): Group I, vehicle control; 
Group II, diabetic control (STZ-NA); Group III, standard treated, 
glibenclamide (0.5 mg/kg); Groups IV and V, EEBVR administered 
(200 and 400 mg/kg); and Groups VI and VII, AEBVR treated (200 and 
400 mg/kg). The standard drug, EEBVR, and AEBVR at the prescribed 
doses were administered once daily orally to the respective group 
animals for 21 days. The animals were weighed, and the fasting blood 
glucose levels were estimated using blood glucose test strips on the 
7th, 14th, and 21st days. After the assessment of fasting blood glucose 
levels on the 21st day, blood was collected by retro-orbital plexus and 
centrifuged at 2500 rpm for 10 min to estimate TG and TC [13]. Later, 
the animals were sacrificed under ether anesthesia to isolate liver for 
the estimation of malondialdehyde (MDA), reduced glutathione (GSH), 
glycogen levels [14,15], and pancreas for histopathological studies.
Statistical analysis
The results obtained were statistically analyzed by one-way ANOVA 
followed by Tukey’s Kramer multiple comparison tests and the values 
were expressed as Mean±SEM (n=6). The analysis was carried out using 
GraphPad InStat V-3 software.
RESULTS
Phytochemical screening
The preliminary phytochemical screening of B. vahlii root extract 
revealed the presence of phytosterols, fats, proteins, carbohydrates, 
saponins, phenolic compounds, and tannins.
Acute toxicity study
EEBVR and AEBVR were found to be safe without any signs of toxicity at 
2000 mg/kg. Hence, 1/10th (200 mg/kg) and 1/5th (400 mg/kg) of the 
tested dose were selected for the antidiabetic study.
Antidiabetic activity
STZ-NA administration resulted in the elevation of blood glucose, serum 
TG, TC, liver MDA, decrease in body weight, depletion of liver GSH, and 
glycogen levels. The animals administered with the standard drug 
glibenclamide showed a significant reduction (p<0.001) in the fasting 
blood glucose levels on the 7th day. The diabetic animals treated with 
EEBVR and AEBVR at both the test doses exhibited significant lowering 
(p<0.001) of fasting blood glucose levels on 14 days itself compared to 
diabetic control animals (Table 1).
Diabetes-induced elevation of serum TG and TC was significantly 
lowered (p<0.001) in the animals treated with glibenclamide. Both the 
tested doses of EEBVR and 400 mg/kg of AEBVR exerted significant 
reduction (p<0.001) in TG and TC levels compared to animals in 
diabetic control. AEBVR at a low dose (200 mg/kg) did not exert any 
significant reduction in TG and TC levels (Table 2).
The altered levels of liver GSH, MDA, and glycogen were significantly 
normalized (p<0.001) in animals with glibenclamide treatment. 
Treatment of animals with EEBVR 400 mg/kg (p<0.001) and 200 mg/kg 
(p<0.05), AEBVR 400 mg/kg (p<0.05) caused significant elevation of 
GSH, while AEBVR administration with 200 mg/kg was not significant 
in rising the GSH level. A significant reduction in MDA was observed 
with EEBVR (200 mg/kg and 400 mg/kg, p<0.001) and AEBVR 
(200 mg/kg, p<0.05; 400 mg/kg, p<0.001). The glycogen levels were 
increased significantly in EEBVR (200 mg/kg and 400 mg/kg, p<0.001), 
AEBVR (400 mg/kg, p<0.05) received animals while the elevation of 
glycogen level in AEBVR (200 mg/kg) was not significant (Table 3).
The restoration of body weight in animals treated with standard, 
EEBVR, and AEBVR at both the doses was found significant (p<0.001) 
on the 21st day against diabetes-induced weight loss (Table 4).
Histopathological study
The pancreas histopathology of vehicle control animals showed normal 
lobular architecture with acinar cells surrounding the islet cells. The 
acinar cells were embedded with intact interlobular connective tissue 
and normally arranged polygonal cells (Fig. 1a). The diabetic control 
animals exhibited congested, dilated blood vessels with inflammatory 
infiltration and degenerated islet cells (Fig. 1b). The standard drug-
treated animals revealed partially regenerated islet cells bounded 
by acinar cells (Fig. 1c). The pancreas of animals administered with 
EEBVR 200 mg/kg showed inflammatory infiltrations, acinar with 
cellular residues (Fig. 1d); whereas EEBVR 400 mg/kg treated animals 
showed mild congestion in blood vessels with normal acinar cells 
(Fig. 1e). Vacuolated cells within the islets, congested blood vessels 
with inflammatory exudates and degenerated islets were observed 
in animals that received AEBVR 200 mg/kg (Fig. 1f), while normal 
acinar cells with mild regeneration of islet cells were noticed in AEBVR 
400 mg/kg treated animals (Fig. 1g).
Table 1: Effect of Bauhinia vahlii on fasting blood glucose levels in STZ‑NA‑induced diabetic animals
Group and treatment 0 day (mg/dl) 7th day (mg/dl) 14th day (mg/dl) 21st day (mg/dl)
Vehicle control
Vehicle 98.83±2.44 99.33±1.25 99.83±1.85 99.16±1.15
Diabetic control
Vehicle 272.16±5.98# 299.83±8.00# 323.50±7.27# 357.33±6.15#
Glibenclamide
0.5 mg/kg 280.66±4.93 228.83±1.32*** 179.50±1.02*** 132.33±1.20***
EEBVR
200 mg/kg 277.66±2.52 265.50±2.20* 244.50±1.89*** 227.33±4.87***
400 mg/kg 276.33±5.06 261.16±2.18** 242.83±2.73*** 222.16±2.33***
AEBVR
200 mg/kg 275.50±2.48 273.33±1.89* 257.16±1.42*** 237.83±2.96***
400 mg/kg 276.33±4.90 271.50±2.11* 255.16±1.19*** 235.16±3.03***
Values are expressed as Mean±SEM. Data were analyzed by one-way ANOVA followed by Turkey’s Kramer Multiple Comparison test. #p<0.001, compared to 
vehicle control. *p<0.05, **p<0.01, ***p<0.001, compared to diabetic control group. STZ: Streptozotocin, NA: Nicotinamide, EEBVR: Ethanol extract of B. vahlii root, 
AEBVR: Aqueous extract of B. vahlii root, SEM: Standard error of mean
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DISCUSSION
STZ is a glycoside from Streptomyces achromogenes possessing the 
potent alkylating property and selective pancreatic islet beta cell 
cytotoxicity. The uptake of STZ by β cells results in the formation of 
superoxide radicals. Moreover, STZ also liberates nitric oxide leading 
to the destruction of β-cells. NA was intraperitoneally administered 
to activate the polymeric adenosine diphosphate ribose synthase that 
repairs the damaged deoxyribonucleic acid caused by STZ [12,16] thus 
creating a model similar to type 2 DM.
Glibenclamide acts by inhibiting ATP dependent potassium channels 
of beta cells in the pancreas, augments insulin secretion and increase 
the insulin-dependent tissues sensitivity resulting in glucose 
utilization [17]. The significant reduction in fasting blood glucose levels 
of animals treated with EEBVR and AEBVR may be attributed to the 
supportive action of drug extracts in glucose utilization.
DM is associated with a remarkable increase in serum TG and TC levels. 
Insulin activates lipoprotein lipase for the hydrolysis of TG; hence, its 
deficiency causes less inactivation of lipoprotein lipase and a rise in TG 
level is noticed. In addition, insulin deficiency is also associated with an 
increase in serum TC due to metabolic abnormalities [18]. Treatment 
of animals with EEBVR and AEBVR significantly reduced the serum TG 
and TC level compared to diabetic control animals.
GSH is an endogenous antioxidant very much essential for cellular 
protection [19]. EEBVR and AEBVR treatment of animals exhibited 
significant restoration of liver GSH in dose-dependent manner. Lipid 
peroxidation causes cell membrane destruction by free radicals [19] 
and the estimation of lipid peroxidation in terms of MDA levels directly 
reflects the extent of oxidative damage occurred. The elevation in 
Table 2: Effect of Bauhinia vahlii on serum TG and TC in 
STZ‑NA‑induced diabetic animals






0.5 mg/kg 92.66±1.47*** 83.16±2.53***
EEBVR
200 mg/kg 134.16±1.92*** 111.16±1.92***
400 mg/kg 123.33±1.39*** 103.33±2.82***
AEBVR
200 mg/kg 148.66±1.49 123.33±1.83
400 mg/kg 136.16±1.30*** 110.33±0.88***
Values are expressed as Mean±SEM. Data were analyzed by one-way ANOVA 
followed by Turkey’s Kramer Multiple Comparison test. #p<0.001, compared 
to vehicle control. *p<0.05, **p<0.01, ***p<0.001, compared to diabetic 
control group. TG: Triglycerides, TC: Total cholesterol, STZ: Streptozotocin, NA: 
Nicotinamide, EEBVR: Ethanol extract of B. vahlii root, AEBVR: Aqueous extract 
of B. vahlii root, SEM: Standard error of mean
Table 3: Effect of Bauhinia vahlii on liver GSH, MDA, and Glycogen in STZ‑NA‑induced diabetic animals
Group/treatment GSH (nm/100 mg tissue) MDA (TBARS nm/100 mg tissue) Glycogen (mg/100 mg tissue)
Vehicle control
Vehicle 65.07±1.29 0.20±0.02 6.53±0.29
Diabetic control
Vehicle 29.65±0.53# 0.43±0.02# 1.88±0.16#
Glibenclamide
0.5 mg/kg 52.81±1.01*** 0.22±0.01*** 5.12±0.14***
EEBVR
200 mg/kg 36.32±1.20* 0.30±0.01*** 3.75±0.34***
400 mg/kg 41.97±2.24*** 0.25±0.02*** 4.29±0.22***
AEBVR
200 mg/kg 31.38±0.89 0.34±0.01* 2.77±0.20
400 mg/kg 36.44±1.92* 0.30±0.01*** 3.24±0.42*
Values are expressed as Mean±SEM, Data were analyzed by one-way ANOVA followed by Turkey’s Kramer Multiple Comparison test. #p<0.001, compared to vehicle 
control, *p<0.05, **p<0.01, ***p<0.001, compared to diabetic control group. GSH: Reduced glutathione, MDA: Malondialdehyde, STZ: Streptozotocin, NA: Nicotinamide, 
EEBVR: Ethanol extract of B. vahlii root, AEBVR: Aqueous extract of B. vahlii root, SEM: Standard error of mean
Fig. 1: (a‑g) Pancreas histopathology of animals treated 
with EEBVR and AEBVR in STZ‑NA‑induced diabetes (×40). 
IC: Islet cells, CT: Connective tissue, AC: Acinar cells, DCV: 
Dilated, congested vessel, CRS: Cellular residue, VC: Vacuole, II: 
Inflammatory infiltration, STZ: Streptozotocin, NA: Nicotinamide, 
EEBVR: Ethanol extract of B. vahlii root, AEBVR: Aqueous extract 
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hepatic MDA levels caused by STZ-NA was significantly brought down 
in the animals administered with EEBVR and AEBVR.
A decrease in liver glycogen content in diabetic animals was observed 
which might be due to decreased glycogen synthesis or increased 
glycogenolysis [20]. This decreased hepatic glycogen in the animals 
treated with STZ-NA was significantly increased by EEBVR and AEBVR 
in a dose-dependent fashion.
Diabetes-induced weight loss may be attributed to muscle wasting and 
catabolism of tissue proteins. A significant reversal of weight loss is 
observed in animals administered with EEBVR and AEBVR.
The studies reported earlier by various researchers have established 
the antidiabetic activity of phenolic compounds and tannins [21,22] 
and saponins [23,24] in DM. The antidiabetic potential of B. vahlii 
against STZ-NA induced diabetes may be ascribed to the presence of the 
above said phytoconstituents that would have resulted in a significant 
reduction of fasting blood glucose level and restoration of body weight. 
Moreover, the depleted liver GSH, glycogen, and the elevated MDA levels 
were significantly restored as compared to diabetic control animals 
which suggest the protective action against liver in STZ-NA-induced 
oxidative stress.
CONCLUSION
The present work confirms the antidiabetic activity of B. vahlii root 
against STZ-NA-induced DM. Among the extracts screened, EEBVR 
400 mg/kg exhibited a significant effect in lowering blood glucose 
levels, restoration of animal weight and also in reverting the serum 
TG, TC levels; liver GSH, MDA, and glycogen content. The result also 
supports the traditional use in the treatment of diabetes and thus 
provides an alternate source to the Ayurveda drug, Murva.
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Values are expressed as Mean±SEM, Data were analyzed by one-way ANOVA 
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